Drugs / Vivigen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03527966 Comparator | Jul 2017 → Jul 2018 | vertebral column disorder | Virtua Health, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vivigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03527966 ↗ |
| Modality | Cell therapy | “Vivigen, a novel cellular allograft product” NCT03527966 ↗ |